RBI reform plan for derivatives: Central bank proposes new norms for novation of OTC derivative contracts, draft guidelines seek to streamline market operations ...

Healthcare technology company Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure monitor, G0 Blood Pressure Monitoring System, also known as the Hilo Band.

Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in one healthcare system formulary led to increased healthcare utilization ...

Overweight or obesity in COPD is linked with a higher prevalence of comorbid diseases, including hypertension, diabetes, osteoarthritis, and heart failure compared with normal weight.

Merck has agreed to a $10-billion buyout of Verona Pharma and its first-in-class, potential COPD blockbuster Ohtuvayre.

"First subject dosed in Upstream Bio’s Phase II trial of verekitug for COPD" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Roman Reigns to form new faction with 4 stars, OTC to win world title? 4 booking steps for The Tribal Chief vs. The Rock at WrestleMania 42 ...

Merck is paying about $10 billion for Verona Pharma, expanding its respiratory disease drug portfolio.

Roche’s astegolimab met the main goal of one pivotal COPD study but failed another, mirroring the mixed results recently posted by a Regeneron Pharmaceuticals COPD drug candidate that goes after ...

The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.